Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

ROMJ.V

HoldHot Air

Rubicon Organics Inc. · Healthcare · Canada · $29M · Avg Vol: $39K/d

53
StockRank
Get insider-trade alerts
Q
47
V
45
M
55
P/E (TTM)
ROE
-4.1%
D/E
0.4x
Dividend %

COMPANY DESCRIPTION

Rubicon Organics Inc., together with its subsidiaries, engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

FINANCIAL SUMMARY (CAD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue35.5M40.1M48.7M59.5M18.7%64.3M74.0M86.5M20.6%
EPS (CAD)-0.07-0.03-0.040.02-0.02
Shares56.1M56.2M56.5M67.2M+19.7%67.6M
Debt10.2M10.4M9.9M12.4M6.7%15.6M
Equity38.3M37.9M37.4M44.1M4.7%
Op CF2.0M5.0M3.4M-3.0M32.0%-2.5M
Inv CF-4.5M-2.7M-1.5M-8.4M
Fin CF-0.8M-0.8M-1.8M5.7M
Loading 1Y...
PRICE (1Y)+6.7%
0.320.350.370.400.43Jul 24Aug 17Sep 4
SMA 50SMA 200

Close
$0.3475
RSI (14)
51.9
52W High
$0.4778
From 52W High
0.7%

SCORE BREAKDOWN

Quality
47
ROIC
-1.2%46.1
ROE
-4.1%42.9
GP/Assets
34.7%71.9
Op. Margin
3.7%52.1
FCF/Assets
-14.9%26.8
Piotroski
550.6
Int. Cover
-0.8x36.8
D/E Ratio
0.37x36.5
Current Ratio
2.21x41.7
Value
45
P/E (TTM)
N/A
EV/EBITDA
16.7x39.8
P/FCF
N/A
P/B
0.8x91.1
P/S
0.5x92.1
Div Yield
N/A
Momentum
55
52W High %
73%54.5
RS 6M
-10%51.1
SMA 50/200
1.00x60.3
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+646%97.0
Q Growth
-47%12.2

FUNDAMENTALS

Market Cap
$29M
P/E (Forward)
4.4x
Gross Margin
36.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ROMJ.V are excluded.

TickerCompanyMkt CapStockRankSignal
ROMJ.VRubicon Organics Inc.(you)$29M53Hold
LEEF.CNLeef Brands Inc.$58M42Hold
DB.VDecibel Cannabis Company Inc.$51M67Buy
MLCO.CNThe More Life Company Corp.$26M23Sell
HLS.TOHLS Therapeutics Inc.$80M66Buy
VM.VVoyageur Pharmaceuticals Ltd.$28M19Strong Sell
LSL.VLSL Pharma Group Inc.$30M15Strong Sell
OPTI.CNOptimi Health Corp.$27M12Strong Sell
OGIOrganigram Global Inc.$171M63Hold
TSND.TOTerrAscend Corp.$243M60Hold

Peer medians: ROE -37.9% · P/E 17.3x · Gross margin 45.1%

Rubicon Organics Inc. (ROMJ.V): Stock Score Summary

Rubicon Organics Inc. (ROMJ.V) has a MoatMap StockRank of 53/100 based on Quality (47/100), Value (45/100), and Momentum (55/100) factor scores. The current signal is HOLD.

Rubicon Organics Inc., together with its subsidiaries, engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Key Financial Metrics

Price$0.35
Market Cap$29M
P/E (Forward)4.40
Price/Book0.77
Return on Equity-4.1%
Return on Invested Capital-1.2%
Debt/Equity0.37x
Gross Margin36.0%
Operating Margin3.7%
Revenue Growth23.1%
Free Cash Flow$-7M

Rubicon Organics Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is Rubicon Organics Inc.’s (ROMJ.V) StockRank?
MoatMap’s StockRank for Rubicon Organics Inc. (ROMJ.V) is 53/100, with a Hold signal. It is a composite of Quality (47), Value (45), and Momentum (55) factor ranks across MoatMap’s 20,000+ stock universe.
Does Rubicon Organics Inc. have an economic moat?
Rubicon Organics Inc. (ROMJ.V) has a Quality factor score of 47/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Rubicon Organics Inc. a buy, hold, or sell?
MoatMap’s current signal for Rubicon Organics Inc. (ROMJ.V) is Hold, based on a StockRank of 53/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Rubicon Organics Inc. in?
Rubicon Organics Inc. (ROMJ.V) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Canada).